M2care
Overview
M2care is a European healthtech venture studio that co-founds, develops, and finances early-stage innovative healthcare projects by bridging the gap between academia, investors, and industry.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Maculaser | Aug 2026 | VC Round | Lead |
| Rhovica Neuroimaging AG | Aug 2025 | Pre Seed | Lead |
| TheraSonic | May 2024 | Pre Seed | Lead |
Key People
Sophie HUMBERT
Senior Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is M2care based?
M2care is headquartered in Lyon, France.
When was M2care founded?
M2care was founded in 2017.
How many portfolio companies does M2care have?
M2care has 3 portfolio companies in Caplight's dataset.
What are some companies in M2care's portfolio?
Portfolio companies visible on Caplight include Maculaser, Rhovica Neuroimaging AG, TheraSonic.
What was M2care's most recent investment shown here?
M2care's most recent investment in this portfolio sample was in Maculaser in 2026.
What sectors does M2care focus on?
M2care focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does M2care focus on?
M2care typically invests at the Early stage.
What is M2care's AUM?
M2care's assets under management are estimated between $27.8M and $27.8M.